x

Compass Therapeutics, Inc. (Nasdaq:CMPX)

Health Care/Life Sciences • Biotechnology
CIK 1738021
Company

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Address
80 Guest Street
Suite 601
Boston, Massachusetts 02135
Employees
26
Stock Info
Close
$1.9200
Day Range
1.8100 - 2.0000
52 Week Range
1.1500 - 3.6800
Average volume
525.51K
Short Interest
1.97M (02/15/24)
% of Float Shorted
2.59%
Market Cap
$249.87M
Revenue
N/A
Net Income
-$39.23M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$0.3292
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
Vered Bisker-Leib PhD, MBA
Vice Chairman, President-Research & Development
Thomas J Schuetz MD, PhD
Chairman
Carl Lee Gordon PhD, CFA
Independent Director
Ellen V Chiniara
Independent Director
Mary Ann Gray PhD
Independent Director
Phil J Ferneau MBA
Independent Director
James P Boylan MBA
Independent Director
Richard Scott Lindahl MBA
SEC filings
DateFormEvent
10 Dec, 2024 8-K
10 Dec, 2024 4
10 Dec, 2024 3
10 Dec, 2024 3
14 Nov, 2024 SC 13G/A
12 Nov, 2024 10-Q
12 Nov, 2024 8-K
6 Sep, 2024 EFFECT
4 Sep, 2024 CORRESP
3 Sep, 2024 UPLOAD
30 Aug, 2024 S-3
14 Aug, 2024 4
12 Aug, 2024 10-Q
12 Aug, 2024 8-K
9 Aug, 2024 3
2 Aug, 2024 SC 13G
17 Jun, 2024 8-K
29 May, 2024 DEFA14A
28 May, 2024 8-K
13 May, 2024 8-K
13 May, 2024 10-Q
29 Apr, 2024 DEFA14A
29 Apr, 2024 ARS
29 Apr, 2024 DEF 14A
25 Apr, 2024 8-K
22 Mar, 2024 SC 13D/A
21 Mar, 2024 8-K
21 Mar, 2024 10-K
11 Mar, 2024 4
14 Feb, 2024 4
14 Feb, 2024 4
14 Feb, 2024 4
14 Feb, 2024 4
14 Feb, 2024 4
9 Feb, 2024 SC 13G/A
9 Feb, 2024 4
9 Feb, 2024 4
7 Feb, 2024 SC 13G/A
1 Feb, 2024 SC 13G
10 Jan, 2024 4
10 Jan, 2024 4
9 Jan, 2024 8-K CEO Change
5 Jan, 2024 8-K
27 Nov, 2023 SC 13G
21 Nov, 2023 4
21 Nov, 2023 4
9 Nov, 2023 10-Q
9 Nov, 2023 8-K
3 Aug, 2023 8-K
3 Aug, 2023 10-Q
15 Jun, 2023 8-K
4 May, 2023 8-K
4 May, 2023 10-Q
27 Apr, 2023 DEFA14A
27 Apr, 2023 DEF 14A
27 Apr, 2023 ARS
24 Apr, 2023 3
24 Apr, 2023 4
24 Apr, 2023 8-K
15 Mar, 2023 10-K
10 Mar, 2023 8-K
10 Mar, 2023 4
27 Feb, 2023 4
24 Feb, 2023 8-K
15 Feb, 2023 4
14 Feb, 2023 SC 13G/A
13 Feb, 2023 SC 13G/A
10 Feb, 2023 4
10 Feb, 2023 3
10 Feb, 2023 8-K
9 Feb, 2023 4
9 Feb, 2023 4
9 Feb, 2023 4
9 Feb, 2023 4
9 Feb, 2023 4
9 Feb, 2023 SC 13G/A
9 Feb, 2023 4
31 Jan, 2023 4
24 Jan, 2023 424B3
24 Jan, 2023 4
20 Jan, 2023 EFFECT
19 Jan, 2023 8-K
19 Jan, 2023 CORRESP
17 Jan, 2023 CORRESP
13 Jan, 2023 CORRESP
7 Dec, 2022 UPLOAD
2 Dec, 2022 S-3
29 Nov, 2022 8-K
22 Nov, 2022 4
14 Nov, 2022 SC 13D
10 Nov, 2022 3
10 Nov, 2022 SC 13D/A
10 Nov, 2022 4
10 Nov, 2022 4
9 Nov, 2022 10-Q
2 Nov, 2022 8-K
28 Sep, 2022 4
27 Sep, 2022 4
8 Sep, 2022 4
1 Sep, 2022 4
19 Aug, 2022 8-K
17 Aug, 2022 4
10 Aug, 2022 4
2 Aug, 2022 4
1 Aug, 2022 10-Q
1 Aug, 2022 8-K
1 Aug, 2022 424B5
21 Jun, 2022 4
17 Jun, 2022 4
13 Jun, 2022 4
7 Jun, 2022 4
1 Jun, 2022 4
31 May, 2022 8-K
26 May, 2022 4
24 May, 2022 4
18 May, 2022 DEFA14A
17 May, 2022 4
13 May, 2022 4
13 May, 2022 4
10 May, 2022 4
10 May, 2022 4
10 May, 2022 4
9 May, 2022 10-Q
4 May, 2022 8-K
28 Apr, 2022 4
28 Apr, 2022 3
28 Apr, 2022 4
28 Apr, 2022 DEF 14A
28 Apr, 2022 3
26 Apr, 2022 8-K
18 Mar, 2022 10-K
25 Feb, 2022 8-K
23 Feb, 2022 4/A
23 Feb, 2022 4
23 Feb, 2022 4
23 Feb, 2022 4
23 Feb, 2022 4
23 Feb, 2022 4/A
23 Feb, 2022 4/A
18 Feb, 2022 4
18 Feb, 2022 4
18 Feb, 2022 4
15 Feb, 2022 SC 13G/A
9 Feb, 2022 SC 13G/A
20 Jan, 2022 8-K
30 Dec, 2021 SC 13G
21 Dec, 2021 8-K
17 Dec, 2021 SC 13G/A
15 Dec, 2021 424B5
15 Dec, 2021 424B5
18 Nov, 2021 4
18 Nov, 2021 4
12 Nov, 2021 SC 13G
12 Nov, 2021 10-Q
9 Nov, 2021 SC 13D/A
8 Nov, 2021 4
8 Nov, 2021 4
3 Nov, 2021 8-K
3 Nov, 2021 424B5
1 Nov, 2021 CERT
1 Nov, 2021 8-K
1 Nov, 2021 424B5
1 Nov, 2021 8-A12B
8 Oct, 2021 8-K
16 Aug, 2021 10-Q
5 Aug, 2021 8-K/A
20 Jul, 2021 EFFECT
16 Jul, 2021 CORRESP
15 Jul, 2021 UPLOAD
14 Jul, 2021 SC 13D/A
9 Jul, 2021 S-3
30 Jun, 2021 8-K
29 Jun, 2021 3
29 Jun, 2021 4
4 Jun, 2021 8-K
13 May, 2021 8-K
5 May, 2021 3
5 May, 2021 4
30 Apr, 2021 10-Q
30 Apr, 2021 424B3
29 Apr, 2021 DEF 14A
19 Apr, 2021 8-K
11 Mar, 2021 424B3
8 Mar, 2021 EFFECT
5 Mar, 2021 POS AM
5 Mar, 2021 10-K
1 Mar, 2021 4
1 Mar, 2021 4
8 Feb, 2021 SC 13G/A
14 Jan, 2021 S-8
Last update:2024-03-08 12:05:50.925301
Compass Therapeutics, Inc. by TradingView

Sign Up to Subscribe